Last reviewed · How we verify
Wujia Yizhi granules
Wujia Yizhi granules is a Small molecule drug developed by Sichuan Jishengtang Pharmaceutical Co., Ltd.. It is currently in Phase 3 development for Traditional Chinese medicine for digestive system disorders.
Wujia Yizhi granules' mechanism is not well-documented.
Wujia Yizhi granules' mechanism is not well-documented. Used for Traditional Chinese medicine for digestive system disorders.
At a glance
| Generic name | Wujia Yizhi granules |
|---|---|
| Sponsor | Sichuan Jishengtang Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on the exact mechanism of action of Wujia Yizhi granules.
Approved indications
- Traditional Chinese medicine for digestive system disorders
Common side effects
- Unknown
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Wujia Yizhi granules CI brief — competitive landscape report
- Wujia Yizhi granules updates RSS · CI watch RSS
- Sichuan Jishengtang Pharmaceutical Co., Ltd. portfolio CI